The last safety study, the so called RIPT-test where 100 persons were to be examined for skin reactions following repeated applications of Zonase have now been finalized without any negative results. This implies that Zonase is the only safety tested exfoliating ingredient for cosmetics where no negative effects are proven even at very high concentrations. Hence, Zonase will be able to provide new and improved qualities to a broad spectre of the cosmetic product categories in trade today, as well as being a basis for developing new products.
Following this, ABT has been in a series of meetings in the USA with several of the leading cosmetic producers in the world, which also has been given the opportunity to test Zonase in their own laboratories.
The response has been very positive and several of the mentioned producers now wish to start negotiations as soon as possible, preferably on an exclusive basis to be able to launch own product series containing ABT's enzyme Zonase. Progress for such negotiations is being scheduled and could take place continuously.